Daiki Mori

451 total citations
19 papers, 368 citations indexed

About

Daiki Mori is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Daiki Mori has authored 19 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in Daiki Mori's work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Daiki Mori is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Daiki Mori collaborates with scholars based in Japan, France and United States. Daiki Mori's co-authors include Hiroyuki Kusuhara, Yuichi Sugiyama, Kazuya Maeda, Kenichi Furihata, Takashi Yoshikado, Osamu Ando, Nobuaki Watanabe, Yusuke Kondo, Linda S. Wood and Manoli Vourvahis and has published in prestigious journals such as Organic Letters, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Daiki Mori

19 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daiki Mori Japan 10 235 131 125 61 35 19 368
Nathan D. Pfeifer United States 10 251 1.1× 141 1.1× 113 0.9× 51 0.8× 11 0.3× 14 409
Ruth Lightfoot-Dunn United States 6 194 0.8× 182 1.4× 95 0.8× 41 0.7× 8 0.2× 9 341
B. Kevin Park United Kingdom 13 93 0.4× 157 1.2× 64 0.5× 151 2.5× 25 0.7× 15 485
Esther G. van de Kerkhof Netherlands 6 224 1.0× 180 1.4× 57 0.5× 128 2.1× 99 2.8× 8 551
Saki Izumi Japan 10 385 1.6× 192 1.5× 198 1.6× 66 1.1× 21 0.6× 13 467
Sagnik Chatterjee India 9 322 1.4× 188 1.4× 117 0.9× 104 1.7× 45 1.3× 15 551
Wei Duan China 7 253 1.1× 71 0.5× 76 0.6× 174 2.9× 15 0.4× 20 471
Eman El‐Khateeb Egypt 11 134 0.6× 133 1.0× 52 0.4× 90 1.5× 14 0.4× 25 378
Git Chung United Kingdom 9 142 0.6× 62 0.5× 91 0.7× 160 2.6× 63 1.8× 14 381
Yoshitake Furuta Japan 5 233 1.0× 96 0.7× 91 0.7× 84 1.4× 6 0.2× 10 351

Countries citing papers authored by Daiki Mori

Since Specialization
Citations

This map shows the geographic impact of Daiki Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daiki Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiki Mori more than expected).

Fields of papers citing papers by Daiki Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daiki Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daiki Mori. The network helps show where Daiki Mori may publish in the future.

Co-authorship network of co-authors of Daiki Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Daiki Mori. A scholar is included among the top collaborators of Daiki Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daiki Mori. Daiki Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mori, Daiki, et al.. (2024). Recognition of target domain Japanese speech using language model replacement. EURASIP Journal on Audio Speech and Music Processing. 2024(1). 1 indexed citations
2.
Sakaguchi, Aya, et al.. (2023). Incomplete fusion reaction producing Pa nuclides in the 232Th + 7Li reaction. Radiochimica Acta. 111(8). 589–596. 1 indexed citations
3.
Mori, Daiki, et al.. (2022). Implicit language information replacing method in Japanese encoder–decode ASR model. 1–6. 1 indexed citations
5.
Takashima, Hiroki, Yoshikatsu Koga, Shino Manabe, et al.. (2021). Radioimmunotherapy with an 211At‐labeled anti–tissue factor antibody protected by sodium ascorbate. Cancer Science. 112(5). 1975–1986. 12 indexed citations
6.
Manabe, Shino, Hiroki Takashima, Yoshikatsu Koga, et al.. (2021). Stabilization of an 211At-Labeled Antibody with Sodium Ascorbate. ACS Omega. 6(23). 14887–14895. 5 indexed citations
7.
Danoy, Mathieu, Yannick Tauran, Stéphane Poulain, et al.. (2021). Multi‐omics analysis of hiPSCs‐derived HLCs matured on‐chip revealed patterns typical of liver regeneration. Biotechnology and Bioengineering. 118(10). 3716–3732. 12 indexed citations
8.
Mori, Daiki, Hiroo Ishida, Tadahaya Mizuno, et al.. (2020). Alteration in the Plasma Concentrations of Endogenous Organic Anion–Transporting Polypeptide 1B Biomarkers in Patients with Non–Small Cell Lung Cancer Treated with Paclitaxel. Drug Metabolism and Disposition. 48(5). 387–394. 29 indexed citations
9.
Danoy, Mathieu, Yannick Tauran, Stéphane Poulain, et al.. (2020). Analysis of hiPSCs differentiation toward hepatocyte-like cells upon extended exposition to oncostatin. Differentiation. 114. 36–48. 5 indexed citations
10.
Kusuhara, Hiroyuki, Daiki Mori, Hiroo Ishida, et al.. (2020). P74 - Evaluation of endogenous biomarkers of OATP1B activity in patients with non-small cell lung cancer who receive paclitaxel. Drug Metabolism and Pharmacokinetics. 35(1). S44–S44. 1 indexed citations
11.
Ooe, Kazuhiro, Tadashi Watabe, Yoshifumi Shirakami, et al.. (2020). Production and separation of theranostic radionuclide Ag-111 from Pd target. 61. 1116–1116. 1 indexed citations
12.
Watanabe, Nobuaki, et al.. (2019). Effect of Rifampicin on the Plasma Concentrations of Bile Acid-O-Sulfates in Monkeys and Human Liver-Transplanted Chimeric Mice With or Without Bile Flow Diversion. Journal of Pharmaceutical Sciences. 108(8). 2756–2764. 19 indexed citations
13.
Mori, Daiki, Emi Kimoto, Brian Rago, et al.. (2019). Dose‐Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs. Clinical Pharmacology & Therapeutics. 107(4). 1004–1013. 77 indexed citations
14.
Danoy, Mathieu, Keiichi Kimura, Stéphane Poulain, et al.. (2019). Optimized protocol for the hepatic differentiation of induced pluripotent stem cells in a fluidic microenvironment. Biotechnology and Bioengineering. 116(7). 1762–1776. 28 indexed citations
15.
Yoshikado, Takashi, Daiki Mori, Kenichi Furihata, et al.. (2018). Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers. Pharmaceutical Research. 35(7). 138–138. 77 indexed citations
16.
Mori, Daiki, Takashi Yoshikado, Miyuki Kimura, et al.. (2018). Effect of OATP1B1 genotypes on plasma concentrations of endogenous OATP1B1 substrates and drugs, and their association in healthy volunteers. Drug Metabolism and Pharmacokinetics. 34(1). 78–86. 54 indexed citations
17.
Mori, Daiki, Naoki Koide, Hiroshi Nagata, et al.. (2015). Poly I:C enhances production of nitric oxide in response to interferon-γ via upregulation of interferon regulatory factor 7 in vascular endothelial cells. Microvascular Research. 98. 68–73. 9 indexed citations
18.
Mishima, Hideyuki, Daiki Mori, Hiroshi Nagata, et al.. (2014). [Four cases of bevacizumab-related gastrointestinal perforation].. PubMed. 41(12). 2506–8. 2 indexed citations
19.
Morimoto, Minoru, Tetsuya Hayashi, Daiki Mori, et al.. (2013). Depolymerization of sulfated polysaccharides under hydrothermal conditions. Carbohydrate Research. 384. 56–60. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026